Seres Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 05/15/2026 | 1.16 M | $10.25 M | 0.00% | 12.06% |
| 05/15/2026 | 294.14 K | $2.61 M | 100.00% | 3.07% | |
| MARSHALL WACE, LLP | 05/15/2026 | 139.54 K | $1.24 M | 16.11% | 1.46% |
| VONTOBEL HOLDING LTD. | 05/08/2026 | 138.47 K | $1.23 M | 34.13% | 1.45% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 105.34 K | $934.36 K | -41.46% | 1.10% |
| BLACKROCK, INC. | 05/13/2026 | 102.03 K | $904.97 K | -1.54% | 1.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 74.84 K | $664.11 K | -13.13% | 0.78% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 64.90 K | $575.66 K | -22.92% | 0.68% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 62.32 K | $552.74 K | 282.99% | 0.65% |
| CITADEL ADVISORS LLC | 05/15/2026 | 59.50 K | $527.77 K | 38.92% | 0.62% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 56.70 K | $502.93 K | -17.47% | 0.59% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 39.64 K | $351.63 K | 100.00% | 0.41% |
| STATE STREET CORP | 05/15/2026 | 33.90 K | $300.70 K | 0.00% | 0.35% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 31.63 K | $280.56 K | 0.83% | 0.33% |
| LION POINT CAPITAL, LP | 05/15/2026 | 31.57 K | $280.03 K | 0.00% | 0.33% |
| MORGAN STANLEY | 05/15/2026 | 21.70 K | $192.48 K | -13.64% | 0.23% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 18.79 K | $166.70 K | -27.01% | 0.20% |
| NORTHERN TRUST CORP | 05/14/2026 | 14.77 K | $130.97 K | 0.00% | 0.15% |
| INVESCO LTD. | 05/12/2026 | 14.55 K | $129.03 K | 1.30% | 0.15% |
| UBS GROUP AG | 05/05/2026 | 7.03 K | $62.36 K | 66.35% | 0.07% |
| BARCLAYS PLC | 05/15/2026 | 6.51 K | $57.72 K | -12.45% | 0.07% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 3.48 K | $30.89 K | 0.00% | 0.04% |
| SIMPLEX TRADING, LLC | 05/14/2026 | 3.07 K | $27.23 K | 149.19% | 0.03% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 1.98 K | $17.52 K | 100.00% | 0.02% |
| FMR LLC | 05/15/2026 | 1.75 K | $15.54 K | 0.69% | 0.02% |
| 05/07/2026 | 1.48 K | $13.10 K | 0.00% | 0.02% | |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 824 | $7.31 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 794 | $7.04 K | 100.00% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 211 | $1.87 K | -72.70% | 0.00% |
| PHYSICIAN WEALTH ADVISORS, INC. | 04/24/2026 | 142 | $1.26 K | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2026 | 107 | $1.00 K | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 10 | $89 | -96.15% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 04/27/2026 | 8 | $71 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 8 | $70 | 0.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 05/13/2026 | 6 | $18 | 200.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 05/15/2026 | 4 | $36 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| OMERS ADMINISTRATION CORP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Seres Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 72 institutional investors and hedge funds held shares of Seres Therapeutics Inc. The most heavily invested institutionals were:
Flagship Pioneering Inc.: 1.16 M
MARSHALL WACE, LLP: 139,539
Vontobel Holding Ltd.: 138,468
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 105,339
BlackRock, Inc.: 102,026
GEODE CAPITAL MANAGEMENT, LLC: 74,835
24.07% of Seres Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 33.62 M shares in the last 24 months. This purchase volume represents approximately $313.34 M in transactions.